Description
Ascon-F 100 MDI is a combination inhaler manufactured by ACME Laboratories Ltd., containing 100 mcg of Beclometasone Dipropionate and 6 mcg of Formoterol Fumarate per puff. This formulation is designed for the treatment and management of asthma and chronic obstructive pulmonary disease (COPD).
Beclometasone Dipropionate is a potent inhaled corticosteroid that reduces inflammation within the lungs, thereby decreasing the frequency and severity of asthma attacks and improving overall lung function. Formoterol Fumarate is a long-acting beta₂-adrenergic agonist (LABA) that works by relaxing the muscles in the airways, leading to bronchodilation and easier breathing. The combination of these two agents provides both anti-inflammatory and bronchodilatory effects, making it effective for long-term control of asthma and COPD symptoms.
.jpeg)
.png)
.jpeg)
.png)
.png)
.jpeg)
.webp)
.webp)
.webp)
Change Language